| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
B
Inhibitor Causes Leukemia Cell Death through a p38 MAP Kinase-dependent, NF-
B-independent Mechanism
Interdisciplinary Oncology Program [X. H., W. E. J., L. C. M., M. B., A. D., N. R-Z., B. A. B., K. S. Z.] and Departments of Pathology [W. E. J., L. C. M.], Internal Medicine [K. S. Z.], and Biochemistry and Molecular Biology [K. S. Z.], University of South Florida, and the H. Lee Moffitt Cancer Center, Tampa, Florida 33612 [X. H., W. E. J., L. C. M., M. B., A. D., N. R-Z., B. A. B., K. S. Z.]
Treatment of U937 cells with an I
B
phosphorylation inhibitor, Bay 11-7085, induced a rapid phosphorylation of p38 mitogen-activated protein (MAP) kinase, significant apoptosis, extensive necrosis, and a weak phosphorylation of MAP kinase kinase. Bay 11-7085 had no effect on the basal levels of phosphorylated I
B
but completely inhibited phorbol 12-myristate 13-acetate-induced phosphorylation of I
B
. Although Bay 11-7085 prevented phorbol 12-myristate 13-acetate-induced NF-
B nuclear translocation, SN50, a specific inhibitor of nuclear translocation and function of NF-
B, did not induce any significant nuclear/DNA fragmentation, caspase 3 activation, or cell death. The p38 MAP kinase-specific inhibitor, SB203580, completely inhibited the phosphorylation of p38 MAP kinase and significantly decreased Bay 11-7085-induced apoptosis. In contrast, the MAP kinase kinase-specific inhibitor PD98059 had no effect on Bay 11-7085-induced apoptosis. Caspase-specific inhibitor, z-Val-Ala-Asp-fluoromethyl ketone prevented Bay 11-7085-induced activation of caspase 3 but was not able to block Bay 11-7085-induced phosphorylation of p38 MAP kinase. These data suggest that Bay 11-7085 induces apoptosis through a p38 MAP kinase-dependent, NF-
B-independent mechanism.
This article has been cited by other articles:
![]() |
R. G. Uzzo, P. L. Crispen, K. Golovine, P. Makhov, E. M. Horwitz, and V. M. Kolenko Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression Carcinogenesis, October 1, 2006; 27(10): 1980 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yang, M. Bocchetta, B. Kroczynska, A. G. Elmishad, Y. Chen, Z. Liu, C. Bubici, B. T. Mossman, H. I. Pass, J. R. Testa, et al. TNF-{alpha} inhibits asbestos-induced cytotoxicity via a NF-{kappa}B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis PNAS, July 5, 2006; 103(27): 10397 - 10402. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Ling, X. Wang, D. T. Lee, P.C. Tam, S.-W. Tsao, and Y.-C. Wong Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R) Carcinogenesis, April 1, 2004; 25(4): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Ma, H. H. Yang, K. Parker, S. Manyak, J. M. Friedman, C. Altamirano, Z.-q. Wu, M. J. Borad, M. Frantzen, E. Roussos, et al. The Proteasome Inhibitor PS-341 Markedly Enhances Sensitivity of Multiple Myeloma Tumor Cells to Chemotherapeutic Agents Clin. Cancer Res., March 1, 2003; 9(3): 1136 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hu, M. Bryington, A. B. Fisher, X. Liang, X. Zhang, D. Cui, I. Datta, and K. S. Zuckerman Ubiquitin/Proteasome-dependent Degradation of D-type Cyclins Is Linked to Tumor Necrosis Factor-induced Cell Cycle Arrest J. Biol. Chem., May 3, 2002; 277(19): 16528 - 16537. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |